Erin M. Dunbar

Oncology

95 Collier Rd NW
Atlanta, GA 30309

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.

Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.

Journal: medRxiv : the preprint server for health sciences

Published: July 03, 2026

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 07, 2026

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 14, 2026

Practical Management of Headaches in Patients With Primary and Secondary Brain Tumors.

Practical Management of Headaches in Patients With Primary and Secondary Brain Tumors.

Journal: Journal of pain and symptom management

Published: January 26, 2026

Practical management of headaches in patients with primary and secondary brain tumors.

Practical management of headaches in patients with primary and secondary brain tumors.

Journal: Journal of pain and symptom management

Published: January 26, 2026

Guiding principles for adult CNS tumor treatment programs.

Guiding principles for adult CNS tumor treatment programs.

Journal: Neuro-oncology advances

Published: September 22, 2025

Vorasidenib: Patient and caregiver information sheet.

Vorasidenib: Patient and caregiver information sheet.

Journal: Neuro-oncology practice

Published: January 08, 2025

A pilot survey into the landscape of neuro-oncology care in the community.

A pilot survey into the landscape of neuro-oncology care in the community.

Journal: The oncologist

Published: October 01, 2024

Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.

Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.

Journal: Journal of neuro-oncology

Published: December 29, 2023

Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.

Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.

Journal: Cancer

Published: September 16, 2023

A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma.

A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma.

Journal: Tomography (Ann Arbor, Mich.)

Published: December 24, 2022

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.

Journal: JAMA oncology

Published: November 17, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026